Abiomed, Inc.
Abiomed reports revenue is up 28% to $13.8 million
Published in Pharma Investments, Ventures and Law Weekly, June 4th, 2006
Revenue for the fiscal fourth quarter of 2006 was $13.8 million, up 28% compared to revenue of $10.8 million in the same period of fiscal 2005. Revenue for the fiscal year 2006 reached $43.7 million, up 14% over fiscal year 2005 and up 70% over the last 2 years.
Recent financial and operating highlights include:
1) Strong U.S. growth with a 28% increase in total revenue for the quarter and 134% growth in AB5000 Consoles revenue.
2) Total worldwide revenue for consoles (Impella and AB5000) for the fourth quarter...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- A.P. Pharma, Inc.
A.P. Pharma reports income of $0.75 per share; phase III trial for APF530 initiated - Acadia Pharmaceuticals, Inc.
Acadia Pharmaceuticals reports quarterly loss of $9.5 million - Aceto Corp.
Aceto announces earnings per share of $0.11 - Adherex Technologies, Inc.
Adherex announces US$6.5 million private placement - Adolor Corp.
Adolor reports loss of $0.42 per share - Adventrx Pharmaceuticals, Inc.
Adventrx Pharmaceuticals posts loss of $0.31 per share - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
